AdaptHealth price target lowered to $23 from $31 at Baird
The Fly

AdaptHealth price target lowered to $23 from $31 at Baird

Baird analyst Eric Coldwell lowered the firm’s price target on AdaptHealth to $23 from $31 and keeps an Outperform rating on the shares. The analyst said incremental inflationary pressures, gross-to-net revenue adjustments, and variable compensation account for 4Q22 miss. Additionally, growth moderation in some categories, mainly diabetes and respiratory, contributes to incremental 2023 top-line softness.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on AHCO:

Related Articles
TipRanks Auto-Generated NewsdeskAdaptHealth’s Strategic Refinancing for Growth and Efficiency
TipRanks Auto-Generated NewsdeskAdaptHealth Welcomes New COO, Aims for Operational Excellence
TheFlyAdaptHealth appoints Scott Barnhart as COO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App